Meperidine Hydrochloride Injection
Product Images NDC 0641-6052

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Meperidine Hydrochloride (NDC 0641-6052). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Meperidine Hydrochloride Injection Usp 1)

Chemical structure of Meperidine Hydrochloride, showing the molecular arrangement including a phenyl group, an ester linkage, and a hydrochloride component.*

FDA Label Image

Vial (Meperidine Hydrochloride Injection Usp 2)

Packaging label for Meperidine Hydrochloride Injection, USP, 25 mg/mL. The label states administration routes as intramuscular (IM), subcutaneous (SC), or slow intravenous (IV). It is a 1 mL vial manufactured by Hikma Pharmaceuticals USA Inc. The label also includes dosing warnings about not using if precipitated, with spaces for lot number and expiration date.*

FDA Label Image

Sp (Meperidine Hydrochloride Injection Usp 3)

Label for Meperidine HCl Injection, USP 25 mg/mL by Hikma Pharmaceuticals USA Inc. Contains 25 mg/mL meperidine hydrochloride in water for injection, buffered with acetic acid-sodium acetate. Box of 25 single-dose 1 mL vials for intramuscular, subcutaneous, or slow intravenous use. Includes storage instructions and safety warnings. NDC 0641-6052-25.*

FDA Label Image

Vial (Meperidine Hydrochloride Injection Usp 4)

Label for Meperidine Hydrochloride Injection, USP 50 mg/mL, 1 mL vial. The label indicates intramuscular, subcutaneous, or slow intravenous use, warns not to use if precipitated, and includes a lot and expiration date section. Manufactured by Hikma Pharmaceuticals USA Inc. The NDC is 0641-6053-01.*

FDA Label Image

Sp (Meperidine Hydrochloride Injection Usp 5)

Label for Meperidine HCl Injection, USP 50 mg/mL by Hikma Pharmaceuticals USA Inc. The label states the product is for intramuscular, subcutaneous, or slow intravenous use. Each mL contains 50 mg meperidine hydrochloride in water for injection with buffered acetate acid-sodium acetate buffer, pH 3.5-6.0. Package contains 25 x 1 mL single dose vials. Storage instructions are 20° to 25°C (68° to 77°F) under USP controlled room temperature.*

FDA Label Image

Vial (Meperidine Hydrochloride Injection Usp 6)

Label for Meperidine Hydrochloride Injection, USP 100 mg/mL by Hikma Pharmaceuticals USA Inc. The label states the drug is for intramuscular, subcutaneous, or slow intravenous use, with a 1 mL vial size. It warns against use if precipitated and includes NDC 0641-6054-01.*

FDA Label Image

Sp (Meperidine Hydrochloride Injection Usp 7)

Label for Meperidine HCl Injection, USP 100 mg/mL by Hikma Pharmaceuticals USA Inc. The injection is indicated for intramuscular, subcutaneous, or slow intravenous use. The package contains 25 single-dose vials of 1 mL each. The label includes storage instructions and notes it is an Rx-only product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.